ConductScience.org, home

Paper61440

Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.

Purcell RH and 10 others. Lancet, 1976. Cited by 82 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Papers, record 61440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/61440

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2019-06-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Purcell RHR H
2London WTW T
3McAuliffe VJV J
4Palmer AEA E
5Kaplan PMP M
6Gerin JLJ L
7Wagner JJ
8Popper HH
9Lvovsky EE
10Wong DCD C
11Levy HBH B

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon InducersMajor topic
Poly I-CMajor topic
Animals
Chronic Disease
Inclusion Bodies, Viral
Interferons
Liver
Pan troglodytes

Source PubMed

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
32,210,021In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.Viruses2020https://conductscience.org/library/papers/32210021PubMed
29,444,493Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.Curr Opin Virol2018https://conductscience.org/library/papers/29444493PubMed
29,337,856Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.Vaccines (Basel)2018https://conductscience.org/library/papers/29337856PubMed
26,186,123Host-virus interactions in hepatitis B virus infection.Curr Opin Immunol2015https://conductscience.org/library/papers/26186123PubMed
26,033,082The chimpanzee model for hepatitis B virus infection.Cold Spring Harb Perspect Med2015https://conductscience.org/library/papers/26033082PubMed
25,418,467Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.Cell Mol Immunol2015https://conductscience.org/library/papers/25418467PubMed
19,360,120Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.PLoS Pathog2009https://conductscience.org/library/papers/19360120PubMed
10,666,256Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.J Virol2000https://conductscience.org/library/papers/10666256PubMed
7,380,332Liver disease and the e antigen in HBsAg carriers with chronic renal failure.Gut1980https://conductscience.org/library/papers/7380332PubMed
6,253,403
Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.
Infect Immun1980https://conductscience.org/library/papers/6253403PubMed
6,157,363
Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6157363PubMed
631,632Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.Gut1978https://conductscience.org/library/papers/631632PubMed
334,285Interferons: anti-neoplastic drugs?Blut1977https://conductscience.org/library/papers/334285PubMed
196,274Recent advances in the identification of hepatitis viruses.Postgrad Med J1977https://conductscience.org/library/papers/196274PubMed
91,092The hepatitis B virus and its DNA polymerase: the prototype three-D virus.Mol Cell Biochem1979https://conductscience.org/library/papers/91092PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/61440

GET https://conductscience.org/api/papers/v1/61440/authors